Physician profile
Eric Dicicco
NPI 1922010545
$4,473.18
in general payments reported to CMS, 2019-2025
45 companies · $623 in 2025
The $623 reported for 2025 was more than what 77% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $628 · 2020: $278 · 2021: $29.79 · 2022: $655 · 2023: $1,120 · 2024: $1,139 · 2025: $623.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,882.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,882.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $643.54 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $544.11 | 2021-2025 | Vraylar, Ubrelvy, Synthroid |
| Pfizer INC. | $457.70 | 2019-2025 | |
| Glaxosmithkline, LLC. | $296.48 | 2020-2024 | Trelegy Ellipta, Shingrix |
| Astrazeneca Pharmaceuticals LP | $292.22 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $265.67 | 2019-2025 | Zepbound, Jardiance, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $144.83 | 2019-2025 | Jardiance |
| Abbott Laboratories | $129.95 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2, Eterna |
| Sanofi-Aventis U.S. LLC | $121.10 | 2020-2023 | |
| Astellas Pharma US INC | $117.18 | 2019-2024 | Veozah, Myrbetriq |
| Novartis Pharmaceuticals Corporation | $103.69 | 2019-2024 | |
| Shield Therapeutics INC | $97.60 | 2024 | |
| Exact Sciences Corporation | $88.13 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $83.52 | 2019-2025 | Repatha, Otezla, Repatha |
| Otsuka America Pharmaceutical, INC. | $81.04 | 2023-2024 | Rexulti |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Dicicco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.